je.st
news
Celsion: A High Risk/High Reward $2 Biotech Concern
2015-09-05 10:59:30| Biotech - Topix.net
The pullback in the market over the past six weeks has brought significantly lower entry points especially in high beta parts of the market such as the biotech sector. Most of my "dry powder" being currently allocated to this lucrative but volatile sector has gone to the large cap concerns in the space.
Tags: high
concern
reward
biotech
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|